These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8639382)

  • 1. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1996; 16():168-88. PubMed ID: 8639382
    [No Abstract]   [Full Text] [Related]  

  • 2. [Brief overview on the studies of monoclonal antibody].
    Tsukagoshi S
    Nihon Rinsho; 2002 Mar; 60(3):435-8. PubMed ID: 11904954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1994; 15():152-75. PubMed ID: 7779584
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody-interleukin 2 fusion proteins: a new approach to cancer therapy.
    Reisfeld RA; Gillies SD
    J Clin Lab Anal; 1996; 10(3):160-6. PubMed ID: 8731505
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies, cytokines and fusion proteins in the treatment of malignant disease.
    Hank JA; Albertini MR; Sondel PM
    Cancer Chemother Biol Response Modif; 1999; 18():210-22. PubMed ID: 10800484
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].
    Chiron MF
    Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody engineering promotes nanomedicine for cancer treatment.
    Gao J; Feng SS; Guo Y
    Nanomedicine (Lond); 2010 Oct; 5(8):1141-5. PubMed ID: 21039191
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of antibodies and chimeric molecules for cancer immunotherapy.
    Waldmann TA; Morris JC
    Adv Immunol; 2006; 90():83-131. PubMed ID: 16730262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies: does sufficient selectivity to cancer cells exist for therapeutic application?
    Oldham RK
    J Biol Response Mod; 1987 Jun; 6(3):227-34. PubMed ID: 3298552
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of monoclonal antibodies in the treatment of solid tumors].
    Moiseenko VM
    Vopr Onkol; 1999; 45(4):458-62. PubMed ID: 10532114
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting the epidermal growth factor receptor for cancer therapy.
    Mendelsohn J
    J Clin Oncol; 2002 Sep; 20(18 Suppl):1S-13S. PubMed ID: 12235219
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of monoclonal antibodies in the immunotherapy of neoplasms].
    Robak T
    Przegl Lek; 1989; 46(4):420-6. PubMed ID: 2672121
    [No Abstract]   [Full Text] [Related]  

  • 14. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins.
    Xiang J
    Hum Antibodies; 1999; 9(1):23-36. PubMed ID: 10331183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment.
    Magdelaine-Beuzelin C; Kaas Q; Wehbi V; Ohresser M; Jefferis R; Lefranc MP; Watier H
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):210-25. PubMed ID: 17624800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies and fusion proteins in medicine.
    Liossis SN; Tsokos GC
    J Allergy Clin Immunol; 2005 Oct; 116(4):721-9; quiz 730. PubMed ID: 16210042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific antibodies for cancer therapy.
    Hollander N
    Immunotherapy; 2009 Mar; 1(2):211-22. PubMed ID: 20635943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials of antibody therapy.
    Glennie MJ; Johnson PW
    Immunol Today; 2000 Aug; 21(8):403-10. PubMed ID: 10916144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.